Sign in
4

Changes in Ownership

GYRE THERAPEUTICS, INC. Filed Acc 0001209191-20-046348

President & CEO bought 582 shares at $4.81 ($2,799)

From the SEC's structured data for this filing

Trades in this filing

USMAN NASSIM · President & CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2020-08-10 Purchase : show line 1 in the form +582 $4.81 $2,799 11,592 D
Open-market purchases · 582 sh · avg $4.81 · $2,799
Loading xslF345X03/doc4.xml…